• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同意参与并坚持 FORT 随机对照试验的动机。

Motivation to Consent and Adhere to the FORT Randomized Controlled Trial.

机构信息

Ingram School of Nursing, McGill University, Montreal, QC H3A 0G4, Canada.

Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

出版信息

Curr Oncol. 2022 Apr 17;29(4):2848-2863. doi: 10.3390/curroncol29040232.

DOI:10.3390/curroncol29040232
PMID:35448206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9025660/
Abstract

The aim of this qualitative study was to identify the motivational factors that influence cancer survivors to participate and adhere to the fear of cancer recurrence (FCR) FORT randomized controlled trial (RCT). Fifteen women diagnosed with breast and gynecological cancer who took part in the FORT RCT were interviewed about their experience to consent and adhere to the trial. The transcribed interviews were content analyzed within a relational autonomy framework. The analysis revealed that the participants' motivation to consent and adhere to the FORT RCT was structured around thirteen subthemes grouped into four overarching themes: (1) Personal Influential Factors; (2) Societal Motivations; (3) Structural Influences; and (4) Gains in Emotional Support. The unique structures of the trial such as the group format, the friendships formed with other participants in their group and with the group leaders, and the right timing of the trial within their cancer survivorship trajectory all contributed to their motivation to consent and adhere to the FORT RCT. While their initial motivation to participate was mostly altruistic, it was their personal gains obtained over the course of the trial that contributed to their adherence. Potential gains in emotional and social support from psycho-oncology trials should be capitalized when approaching future participants as a mean to improve on motivations to consent and adhere.

摘要

本定性研究旨在确定激励癌症幸存者参与并坚持恐惧癌症复发(FCR)FORT 随机对照试验(RCT)的因素。对参加 FORT RCT 的 15 名被诊断患有乳腺癌和妇科癌症的女性进行了采访,以了解她们同意并坚持试验的经验。在关系自主框架内对转录访谈进行了内容分析。分析结果显示,参与者同意并坚持 FORT RCT 的动机围绕着 13 个小标题组织,分为四个主要主题:(1)个人影响因素;(2)社会动机;(3)结构影响;(4)情感支持的收益。该试验的独特结构,如小组形式、与小组中的其他参与者以及与小组领导建立的友谊,以及试验在癌症生存轨迹中的适当时间,都促成了他们同意并坚持 FORT RCT 的动机。虽然他们最初参与的动机主要是利他主义的,但正是他们在试验过程中获得的个人收益促成了他们的坚持。在招募未来参与者时,应充分利用心理肿瘤学试验可能获得的情感和社会支持方面的潜在收益,以提高同意和坚持的动机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e748/9025660/ed81911637b5/curroncol-29-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e748/9025660/ed81911637b5/curroncol-29-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e748/9025660/ed81911637b5/curroncol-29-00232-g001.jpg

相似文献

1
Motivation to Consent and Adhere to the FORT Randomized Controlled Trial.同意参与并坚持 FORT 随机对照试验的动机。
Curr Oncol. 2022 Apr 17;29(4):2848-2863. doi: 10.3390/curroncol29040232.
2
Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.一项针对乳腺癌或妇科癌症女性的复发恐惧疗法(FORT)干预随机对照试验方案。
BMC Cancer. 2016 Apr 25;16:291. doi: 10.1186/s12885-016-2326-x.
3
Fear of cancer recurrence therapy (FORT): A randomized controlled trial.恐惧癌症复发治疗(FORT):一项随机对照试验。
Health Psychol. 2023 Mar;42(3):182-194. doi: 10.1037/hea0001253.
4
Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors.BLANKET 试验方案:一项关于初级保健干预措施对癌症幸存者癌症复发恐惧的(成本)有效性的集群随机对照试验。
BMJ Open. 2019 Dec 2;9(12):e032616. doi: 10.1136/bmjopen-2019-032616.
5
Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.混合认知行为疗法对乳腺癌、前列腺癌和结直肠癌幸存者高度恐惧复发的长期疗效和成本效益:SWORD 随机对照试验的随访。
BMC Cancer. 2019 May 16;19(1):462. doi: 10.1186/s12885-019-5615-3.
6
Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.探讨一项针对女性癌症幸存者癌症复发恐惧的干预措施初步疗效的随机对照临床试验初步研究。
Support Care Cancer. 2018 Aug;26(8):2751-2762. doi: 10.1007/s00520-018-4097-1. Epub 2018 Mar 2.
7
It's time to address fear of cancer recurrence in family caregivers: usability study of an virtual version of the Family Caregiver-Fear Of Recurrence Therapy (FC-FORT).是时候关注家庭护理人员对癌症复发的恐惧了:家庭护理人员-复发恐惧疗法(FC-FORT)虚拟版本的可用性研究。
Front Digit Health. 2023 Aug 21;5:1129536. doi: 10.3389/fdgth.2023.1129536. eCollection 2023.
8
"As Long as You Ask": A Qualitative Study of Biobanking Consent-Oncology Patients' and Health Care Professionals' Attitudes, Motivations, and Experiences-the B-PPAE Study.“只要你问”:一项关于生物库同意的定性研究——肿瘤患者和医疗保健专业人员的态度、动机和经验——B-PPAE 研究。
Oncologist. 2019 Jun;24(6):844-856. doi: 10.1634/theoncologist.2018-0233. Epub 2018 Nov 9.
9
A focus group study exploring gynecological cancer survivors' experiences and perceptions of participating in a RCT testing the efficacy of a home-based physical activity intervention.一项探索妇科癌症幸存者参与 RCT 试验的经验和看法的焦点小组研究,该 RCT 旨在测试一种基于家庭的体育活动干预的效果。
Support Care Cancer. 2013 Jun;21(6):1697-708. doi: 10.1007/s00520-012-1716-0. Epub 2013 Jan 16.
10
Expectations, experiences and preferences of patients and physicians in the informed consent process for clinical trials in oncology.肿瘤学临床试验知情同意过程中患者和医生的期望、体验和偏好。
Support Care Cancer. 2022 Mar;30(3):1911-1921. doi: 10.1007/s00520-021-06599-7. Epub 2021 Oct 7.

本文引用的文献

1
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors.美国癌症幸存者自述的医疗保健交通障碍。
JAMA Oncol. 2022 May 1;8(5):775-778. doi: 10.1001/jamaoncol.2022.0143.
2
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.“被邀请参与时”:关于患者同意参与癌症临床试验的系统评价与荟萃分析
J Natl Cancer Inst. 2021 Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
3
Effect of Psychological Intervention on Fear of Cancer Recurrence: A Systematic Review and Meta-Analysis.
心理干预对癌症复发恐惧的影响:系统评价和荟萃分析。
J Clin Oncol. 2019 Nov 1;37(31):2899-2915. doi: 10.1200/JCO.19.00572. Epub 2019 Sep 18.
4
Therapeutic factors that promote recovery in high-risk adolescents intensive group psychotherapeutic MBT programme.促进高危青少年康复的治疗因素:强化团体心理治疗MBT项目
Child Adolesc Psychiatry Ment Health. 2019 Jan 10;13:2. doi: 10.1186/s13034-019-0263-6. eCollection 2019.
5
Fear of Cancer Recurrence: A Systematic Review of Randomized, Controlled Trials.癌症复发恐惧:随机对照试验的系统评价
Oncol Nurs Forum. 2018 Nov 1;45(6):703-712. doi: 10.1188/18.ONF.703-712.
6
Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study.患者参与癌症临床试验决策的推理:一项访谈研究。
Trials. 2018 Sep 29;19(1):528. doi: 10.1186/s13063-018-2916-9.
7
Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis.心理躯体干预对癌症复发恐惧的影响:系统评价和荟萃分析。
Psychooncology. 2018 Nov;27(11):2546-2558. doi: 10.1002/pon.4757. Epub 2018 Jun 5.
8
Factors affecting patient participation in clinical trials in Ireland: A narrative review.影响爱尔兰患者参与临床试验的因素:一项叙述性综述。
Contemp Clin Trials Commun. 2016 Mar 2;3:23-31. doi: 10.1016/j.conctc.2016.01.002. eCollection 2016 Aug 15.
9
Patient-centered recruitment and retention for a randomized controlled study.以患者为中心的随机对照研究的招募与保留
Trials. 2018 Mar 27;19(1):205. doi: 10.1186/s13063-018-2578-7.
10
'Recruitment, recruitment, recruitment' - the need for more focus on retention: a qualitative study of five trials.“招募,招募,招募”——需要更加关注留存率:对五项试验的定性研究
Trials. 2018 Jan 29;19(1):76. doi: 10.1186/s13063-018-2467-0.